Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020
Nir Menachemi, Constantin T. Yiannoutsos, Brian E. Dixon, et al.
MMWR Morbidity and Mortality Weekly Report (2020) Vol. 69, Iss. 29, pp. 960-964
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 12, pp. 1123-1138
Open Access | Times Cited: 803
Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status
Shruti Magesh, Daniel John, Wei Tse Li, et al.
JAMA Network Open (2021) Vol. 4, Iss. 11, pp. e2134147-e2134147
Open Access | Times Cited: 569
Infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
Bulletin of the World Health Organization (2020) Vol. 99, Iss. 1, pp. 19-33F
Open Access | Times Cited: 565
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
Daniel P. Oran, Eric J. Topol
Annals of Internal Medicine (2021) Vol. 174, Iss. 5, pp. 655-662
Open Access | Times Cited: 521
Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis
Pratha Sah, Meagan C. Fitzpatrick, Charlotte Zimmer, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 34
Open Access | Times Cited: 451
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis
Panagiotis Galanis, Irène Vraka, Despoina Fragkou, et al.
Journal of Hospital Infection (2020) Vol. 108, pp. 120-134
Open Access | Times Cited: 328
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
Chih-Cheng Lai, Jui-Hsiang Wang, Po‐Ren Hsueh
International Journal of Infectious Diseases (2020) Vol. 101, pp. 314-322
Open Access | Times Cited: 210
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e150-e169
Open Access | Times Cited: 182
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo, Lyn Finelli, David L. Swerdlow
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2033706-e2033706
Open Access | Times Cited: 138
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp‐Thomas, Sally Hunsberger, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 601
Open Access | Times Cited: 132
Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys
Nicholas J. Irons, Adrian E. Raftery
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 31
Open Access | Times Cited: 101
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic
Usha Venugopal, Nargis Jilani, Sami Rabah, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 63-69
Open Access | Times Cited: 117
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Joseph A. Lewnard, Manish M. Patel, Nicholas P. Jewell, et al.
Epidemiology (2021) Vol. 32, Iss. 4, pp. 508-517
Open Access | Times Cited: 100
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco
Gabriel Chamie, Carina Marquez, Emily Crawford, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. Supplement_2, pp. S127-S135
Open Access | Times Cited: 96
Can mHealth Technology Help Mitigate the Effects of the COVID-19 Pandemic?
Catherine Adans-Dester, Stacy Bamberg, Francesco Bertacchi, et al.
IEEE Open Journal of Engineering in Medicine and Biology (2020) Vol. 1, pp. 243-248
Open Access | Times Cited: 84
Leveraging data visualization and a statewide health information exchange to support COVID-19 surveillance and response: Application of public health informatics
Brian E. Dixon, Shaun J. Grannis, Connor McAndrews, et al.
Journal of the American Medical Informatics Association (2021) Vol. 28, Iss. 7, pp. 1363-1373
Open Access | Times Cited: 80
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 5, pp. 1458-1472
Open Access | Times Cited: 79
Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis
Omar Irfan, Li Jiang, Kun Tang, et al.
Journal of Global Health (2021) Vol. 11
Open Access | Times Cited: 77
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Antonio Vena, Marco Berruti, Andrea Adessi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2780-2780
Open Access | Times Cited: 76
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study
Fabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 72
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
Brian E. Dixon, Kara Wools‐Kaloustian, William F. Fadel, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0241875-e0241875
Open Access | Times Cited: 71
Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1762-1771
Open Access | Times Cited: 70
Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence setting
Jordan P. Skittrall, Michael J. Wilson, Anna Smielewska, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 3, pp. 469.e9-469.e15
Open Access | Times Cited: 69
How Many SARS-CoV-2–Infected People Require Hospitalization? Using Random Sample Testing to Better Inform Preparedness Efforts
Nir Menachemi, Brian E. Dixon, Kara Wools‐Kaloustian, et al.
Journal of Public Health Management and Practice (2021) Vol. 27, Iss. 3, pp. 246-250
Open Access | Times Cited: 64
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis
İlker Kayı, Bahar Madran, Şiran Keske, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 9, pp. 1242-1249
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top